FDA hands down RTF letter to rare disease biotech's lead candidate
A rare disease outfit in Princeton, NJ just got its paperwork punted back by the FDA.
Tiny Soligenix reported Tuesday morning …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
